Alkeus and Columbia University enter license agreement for potential treatments for dry-AMD.

Ilyas has shown elegantly, in a mouse style of Stargardt, that somewhat changing vitamin A significantly reduces the rate of formation of these aggregates, preserving visual function eventually. Related StoriesStudy shows supplement D, supplements fail to protect against colorectal cancerAAO announces release of new online reference to improve eye care for childrenElderly females should take more vitamin D supplementation during the wintertime, suggests researchers While these email address details are at the preclinical stage, just how vitamin A interacts with the human body is very well understood and provides us confidence of the low risk and the high potential to deal with these serious ocular illnesses, said Dr. Saad. Various other therapeutic compositions have already been evaluated to reduce the accumulation of these vitamin A aggregates employing more invasive techniques, however the compounds developed by Dr.‘It's also an instrument that allows us to educate our junior colleagues and trainees in ways that's safe and sound, without putting a child at risk.’.

Acacia subsidiary acquires rights to prescription zoom lens technology patent portfolio Acacia Research Corporation announced today that a subsidiary has acquired privileges to a patent portfolio for prescription lens technology. ‘Acacia is quickly becoming the leader in technology licensing and we continue to grow our base of future revenues by adding brand-new patent portfolios,’ concluded Mr. Ryan.

Adding evidence-based weight loss strategies enhances statewide wellness campaign Experts from The Miriam Medical center have discovered that adding evidence-based weight loss strategies to a statewide wellness advertising campaign improves weight reduction outcomes among individuals.